We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer Remains Immune To Lipitor Attack In U.K.

Law360 (June 28, 2006, 12:00 AM EDT) -- Chalking up another win for Pfizer Inc., a British appellate court has upheld the primary patent behind blockbuster cholesterol drug Lipitor, thwarting Ranbaxy Laboratories Ltd. yet again from launching a generic...
To view the full article, register now.